Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125237224 | 12523722 | 4 | F | 20160422 | 20160725 | 20160704 | 20160727 | EXP | IT-ROCHE-1784099 | ROCHE | 54.41 | YR | F | Y | 58.00000 | KG | 20160727 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125237224 | 12523722 | 1 | PS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 103792 | 230 | MG | SOLUTION FOR INFUSION | ||||||||
| 125237224 | 12523722 | 2 | SS | TAXOTERE | DOCETAXEL | 1 | Intravenous (not otherwise specified) | 0 | 80 | MG | SOLUTION FOR INFUSION | ||||||||
| 125237224 | 12523722 | 3 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 0 | 140 | MG | SOLUTION FOR INFUSION | ||||||||
| 125237224 | 12523722 | 4 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 0 | 4920 | MG | SOLUTION FOR INFUSION | ||||||||
| 125237224 | 12523722 | 5 | C | LEDERFOLIN | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 0 | 330 | MG | SOLUTION FOR INFUSION | ||||||||
| 125237224 | 12523722 | 6 | C | ESOMEPRAZOLE SODIUM. | ESOMEPRAZOLE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125237224 | 12523722 | 1 | Oesophageal adenocarcinoma |
| 125237224 | 12523722 | 2 | Oesophageal adenocarcinoma |
| 125237224 | 12523722 | 3 | Oesophageal adenocarcinoma |
| 125237224 | 12523722 | 4 | Oesophageal adenocarcinoma |
| 125237224 | 12523722 | 5 | Oesophageal adenocarcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125237224 | 12523722 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125237224 | 12523722 | Alopecia totalis | |
| 125237224 | 12523722 | Anaemia | |
| 125237224 | 12523722 | Dysgeusia | |
| 125237224 | 12523722 | Hypertransaminasaemia | |
| 125237224 | 12523722 | Nausea | |
| 125237224 | 12523722 | Paraesthesia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125237224 | 12523722 | 1 | 20160418 | 20160530 | 0 | |
| 125237224 | 12523722 | 2 | 20160418 | 20160530 | 0 | |
| 125237224 | 12523722 | 3 | 20160418 | 20160530 | 0 | |
| 125237224 | 12523722 | 4 | 20160418 | 20160530 | 0 | |
| 125237224 | 12523722 | 5 | 20160418 | 20160530 | 0 |